UK markets closed

Calliditas Therapeutics AB (publ) (LC8.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
9.35+0.12 (+1.30%)
As of 09:59AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 490.67M
Enterprise value 490.06M
Trailing P/E N/A
Forward P/E 833.33
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.91
Price/book (mrq)17.70
Enterprise value/revenue 0.41
Enterprise value/EBITDA -1.46

Trading information

Stock price history

Beta (5Y monthly) 1.39
52-week change 3-19.57%
S&P500 52-week change 322.38%
52-week high 313.00
52-week low 36.98
50-day moving average 39.55
200-day moving average 39.06

Share statistics

Avg vol (3-month) 3108
Avg vol (10-day) 3N/A
Shares outstanding 553.67M
Implied shares outstanding 654.12M
Float 837.48M
% held by insiders 116.80%
% held by institutions 140.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in SEK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -38.63%
Operating margin (ttm)5.37%

Management effectiveness

Return on assets (ttm)-12.81%
Return on equity (ttm)-84.68%

Income statement

Revenue (ttm)1.21B
Revenue per share (ttm)22.49
Quarterly revenue growth (yoy)5.20%
Gross profit (ttm)N/A
EBITDA -386.35M
Net income avi to common (ttm)-466.18M
Diluted EPS (ttm)-0.73
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)973.73M
Total cash per share (mrq)18.14
Total debt (mrq)979.13M
Total debt/equity (mrq)292.45%
Current ratio (mrq)3.13
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-434.66M
Levered free cash flow (ttm)-292.03M